FEBRUARY 26-27, 2022 | VIRTUAL

AzPA Spring Clinical Conference 

Proudly Presented by the

ARIZONA PHARMACY ASSOCIATION -state affiliate of ASHP

This 1.5 day seminar provides continuing education for pharmacy professionals focusing on clinical topics pertinent to institutional and ambulatory care settings.

CAN'T ATTEND THE SESSIONS LIVE? NO PROBLEM! ALL SESSIONS WILL BE RECORDED AND MADE AVAILABLE ON-DEMAND AFTER THE CONFERENCE.

REGISTER

Agenda

SATURDAY | FEBRUARY 26TH

8:00 AM | Welcome

Darren Clonts, PharmD, MBA, BCACP-AzPA President; Christopher Edwards, PharmD, BCPS-AzPA HS SIG Director

8:15 AM | Pharmacy Law Update

Roger Morris, RPh, JD-Quarles & Brady; Theresa DeAngelis, JD-Quarles & Brady

Overview of legal and regulatory issues affecting the practice of pharmacy, including interesting topics and a summary of case law relevant to the pharmacy profession. 

Pharmacist/Technician Learning Objectives:

  • Describe new Arizona regulatory updates pertaining to the practice of pharmacy in Arizona.
  • Discuss takeaways and legal standards from recent case law updates pertaining to the practice of pharmacy.

Disclosure: The speakers for this CE activity have no relevant financial relationships with ineligible companies.

ACPE UAN: 0100-0000-22-001-L03-P/T 

Activity Type: Knowledge | CE Credits: 1.5 contact hours

Target Audience: Pharmacists, Technicians

9:45 AM | Non-Accredited Symposium sponsored by Novo Nordisk

2022 ADA Guideline Updates

Jessica Chardoulias, PharmD, BCPS- Novo Nordisk; Isabel Canez, MS, RN, CDCES-Novo Nordisk

10:05 AM | ASHP Update - Featuring a Journey to a Resilient and Thriving Pharmacy Workforce
Nishaminy “Nish” Kasbekar, BS, PharmD, FASHP-Penn Presbyterian Medical Center

Pharmacist/Technician Learning Objectives:

  • Discuss key trends shaping pharmacy practice.
  • Describe ASHP initiatives to meet today’s practice needs.
  • Explain why clinician burnout is a patient care and healthcare workforce problem.
  • Discuss the impact of COVID 19 on wellbeing a resilience.

Disclosure: The speaker for this CE activity has no relevant financial relationships with ineligible companies.

ACPE UAN: 0100-9999-22-002-L04-P/T

Activity Type: Knowledge | CE Credits: 1.5 contact hours

Target Audience: Pharmacists, Technicians

11:35 AM | Non-Accredited Symposium sponsored by MedWise® Science

Advancing Medication Safety by Preventing Adverse Drug Events and Reducing Total Cost of Care

Mindy Smith, BS Pharm, RPh, MHA, CMWA- Tabula Rasa HealthCare 

12:35 PM | Overview of COVID-19 Therapeutics
Mandana Naderi, PharmD, BCIDP-University of Arizona/ADHS; Kelly Fine, RPh, FAzPA-AzPA; Jacob Schwarz, PharmD, MBA, BCIDP, BCCCP, BCPS, FAzPA-Yuma Regional Medical Center; Mohammad Khan, RPh-Walgreens 

Pharmacist Learning Objectives:

  • Discuss the Federal authority granted by HHS to pharmacists/technicians and interns for the ordering and administration of COVID-19 therapeutics.  
  • Identify the available COVID-19 therapeutics recommended for inpatient use. 
  • Summarize the available COVID-19 therapeutics approved for use by FDA for outpatient use. 

Technician Learning Objectives:

  • Discuss the Federal authority granted by HHS to pharmacists/technicians and interns for the ordering and administration of COVID-19 therapeutics. 
  • List the available COVID-19 therapeutics recommended for inpatient use. 
  • List the available COVID-19 therapeutics approved for use by FDA for outpatient use 

Disclosure: The speakers for this CE activity have no relevant financial relationships with ineligible companies.

ACPE UAN: 0100-0000-22-009-L01-P/T

Activity Type: Knowledge | CE Credits: 1.5 contact hours

Target Audience: Pharmacists, Technicians

2:10 PM | Keep It Moving: Avoiding Clinical Inertia in Type 2 Diabetes Management
Brandon M. Ladd, PharmD, BCACP-Cigna Medical Group

The purpose of this proposal is to educate healthcare professionals who manage type 2 diabetes patients on the risks of clinical inertia and how to make timely, effective, and appropriate changes to medication regimens. 

Learning Objectives (Pharmacist Only):

  • Interpret signs of therapeutic inertia in type 2 diabetes patients.
  • Use clinically appropriate strategies for improving diabetes control in a timely manner.
  • Modify a patient's basal insulin dose to correct overbasalization.

Disclosure: The speaker for this CE activity has no relevant financial relationships with ineligible companies.

ACPE UAN: 0100-0000-22-003-L01-P 

Activity Type: Application | CE Credits: 1.0 contact hours

Target Audience: Pharmacists

2:10 PM | Advances in Pharmacotherapy New Drugs Update
Robert J. Lipsy, PharmD, BCACP, FASHP, FAzPA-SinfoniaRx and University of Arizona

An educational presentation of new drugs and biologics approved by the US FDA in the previous the last six months. To educate and prepare pharmacists and pharmacy technicians for the use, monitoring and preparing of novel new therapeutics.

Pharmacist Learning Objectives:

  • Identify clinically important drug-drug interactions that would require dose adjustments of maribavir.
  • Identify the patients for whom finerenone is FDA approved.
  • Identify the patients that difelikefalin has been shown to be effective in.
  • Educate patients in what way(s) atogepant is superior to placebo.

Technician Learning Objectives:

  • Direct a patient to a pharmacist when a patient does not understand the appropriate use for a common use of a drug.
  • Recognize common adverse drug reactions of common classes of drugs or products within those classes.

Disclosure: The speaker for this CE activity has no relevant financial relationships with ineligible companies.

ACPE UAN: 0100-0000-22-004-L01-P/T

Activity Type: Knowledge | CE Credits: 1.5 contact hours

Target Audience: Pharmacists, Technicians

SUNDAY | FEBRUARY 27TH

8:00 AM | Let Your Voice Be Heard: A Discussion of Advocacy and ASHP House of Delegates
Mindy Burnworth, PharmD, BCPS, FASHP, FAzPA-Midwestern University; Christopher Edwards, PharmD, BCPS-University of Arizona/Banner UMC; Danielle Kamm, PharmD-HonorHealth

The goal of this presentation is to share recently adopted policies and upcoming policies that are being reviewed by ASHP House of Delegates for approval or discontinuation. The goal of the town hall is to gather all Arizona Pharmacy Association – ASHP members opinions and voice on such policies being reviewed, prior to the House of Delegates’ Regional Delegate Conference. 

Pharmacist/Technician Learning Objectives:

  • Identify at least two methods of moving an initiative forward to the ASHP House of Delegates.
  • Discuss the role of Arizona delegates to the ASHP House of Delegates.
  • Discuss the potential impact of selected policies coming before the ASHP House of Delegates in June to the practice of pharmacy in Arizona and to pharmacy personnel.

Discosures: The speakers for this CE activity have no relevant financial relationships with ineligible companies.

ACPE UAN: 0100-0000-22-005-L03-P/T

Activity Type: Knowledge | CE Credits: 1.5 contact hours

Target Audience: Pharmacists, Technicians

9:45 AM | Immunization Update-Focus on COVID-19 Vaccines
Holly Van Lew, PharmD, BCPS-Phoenix Indian Medical Center

Pharmacist Learning Objectives:

  • Evaluate patient eligibility for COVID-19 vaccines and boosters.
  • Compare COVID vaccine mRNA and viral vector platform vaccine efficacy and side effect profiles.
  • Describe anticipated future COVID-19 vaccine Emergency Use - Authorization expansions and COVID-19 vaccine product changes.

Technician Learning Objectives:

  • List the available mRNA and viral vector platform COVID-19 vaccines.
  • Describe anticipated future COVID-19 vaccine Emergency Use - Authorization expansions and COVID-19 vaccine product changes.

Disclosure: The speaker for this CE activity has no relevant financial relationships with ineligible companies.

ACPE UAN: 0100-0000-22-006-L06-P/T

Activity Type: Knowledge | CE Credits: 1.0 contact hours

Target Audience: Pharmacists, Technicians

10:45AM | Non-Accredited Symposium sponsored by AzPA  

What is Mental Health First Aid?

Jayden Lee, PharmD, BCACP-Banner Health

11:05 AM | The Ins and Outs of Collaborative Practice Agreements
Darren Clonts, PharmD, MBA, BCACP-Cigna Medical Group; Kelly Fine, RPh, FAzPA-AzPA; Virginia Boomershine, PharmD, BCACP, CDCES-Banner Health

Pharmacist/Technician Learning Objectives:

  • Describe the current laws for collaborative practice agreements in Arizona.
  • Describe the proposed changes to collaborative practice agreement laws in Arizona.
  • Summarize the process for establishing a collaborative practice agreement.

Disclosure: The speakers for this CE activity have no relevant financial relationships with ineligible companies.

ACPE UAN: 0100-0000-22-007-L04-P/T

Activity Type: Knowledge | CE Credits: 1.0 contact hours

Target Audience: Pharmacists, Technicians

11:05 AM | Post-MI Colchicine; A Cold, Hard Look at the Evidence

Kimberly Langley, PharmD, MBA, BCPS-Phoenix Indian Medical Center

Heart disease continues to be a leading cause of death in the US with a 30% mortality rate of those diagnosed with myocardial infarction. Several pharmacological and nonpharmacological strategies have been proven to lower the risk of a recurrent attack. This presentation will review the current evidence for the role of colchine in post-myocardial infarction patients. 

Pharmacists Learning Objectives: (Pharmacist Only)

  • Describe the prevalence and major contributors to the development of heart disease.
  • Analyze the current evidence for colchicine in the post-myocardial infarction patient population.
  • Summarize available evidence-based strategies to reduce risk for myocardial infarction.
  • Discuss the pharmacist’s role in the management of therapy for post-MI patients.

Disclosure: The speaker for this CE activity has no relevant financial relationships with ineligible companies.

ACPE UAN: 0100-0000-22-008-L01-P 

Activity Type: Knowledge | CE Credits: 1.0 contact hours

Target Audience: Pharmacists

 

REGISTER

 Accreditation Information 

The Arizona Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE).

 

Continuing Education

Sessions approved for CE credits are indicated by the CE icon, an ACPE number, and the number of CEUs in the session listing.

 

To obtain CPE credit for any of the LIVE sessions, learners must attend the session live, enter the session code, and complete the assessment quiz and evaluation for each session attended. The session code and further instructions will be provided at the end of each LIVE session.

  • Learning Level: Varies
  • Activity Type: Knowledge and Application-based
  • Target Audience: Pharmacists and Technicians

 

Disclosures

Disclosures will be announced at the beginning of each session and can be found in the Event Program under each speaker(s) biography. AzPA CE staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity.

Conflicts of interest have been resolved through content review by the AzPA CE Committee Department and Committee.